|Articles|October 15, 2002
Neurotech narrows: French research firm to focus on eye technology
Evry, France-Neurotech will refocus its efforts on ophthalmic technologies, halting research and development activities in the fields of neuroscience and cell therapy.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
2
AAO 2025: Advancements in laser refractive surgery
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5














































.png)


